tiprankstipranks
Trending News
More News >
Syndax Pharmaceuticals Inc (SNDX)
NASDAQ:SNDX
US Market
Advertisement

Syndax Pharmaceuticals (SNDX) Financial Statements

Compare
788 Followers

Syndax Pharmaceuticals Financial Overview

Syndax Pharmaceuticals's market cap is currently $1.27B. The company's EPS TTM is $-0.83; its P/E ratio is ―; Syndax Pharmaceuticals is scheduled to report earnings on August 4, 2025, and the estimated EPS forecast is $-0.72. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Currency in USD

Syndax Pharmaceuticals Earnings and Revenue History

Syndax Pharmaceuticals Debt to Assets

Syndax Pharmaceuticals Cash Flow

Syndax Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis